Comprehensive SWOT analysis based on the latest 10-Q filing. Financial overview highlights FNF's robust title insurance segment and strategic acquisitions. Expert insights into FNF's market ...

But the original Venom, Eddie Brock, is getting his own fresh coat of paint as the new bearer of the Carnage symbiote, as announced during Marvel's Spider-Man and his Venomous Friends Panel at New ...

In a report released today, Bose George from KBW maintained a Hold rating on Fidelity National Financial (FNF – Research Report), with a price target of $63.00. The company’s shares closed ...

Fidelity National Financial (FNF) has seen muted mortgage activity but benefits from its stake in F&G Annuities, which has risen over 25%. Title revenue improved but remains 30% below peak levels ...

What will become of Eddie Brock? The answer, it turns out, is that Eddie is becoming the new Carnage. Marvel revealed that intriguing bit of news at the "Spider-Man and His Venomous Friends" panel ...

Fidelity National Financial Trading Down 2.3 % Shares of FNF stock opened at $58.80 on Monday. The company has a current ratio of 0.23, a quick ratio of 0.23 and a debt-to-equity ratio of 0.52 ...